- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
4 result(s) found for: Ceftibuten.
Displaying page 1 of 1.
EudraCT Number: 2008-003209-16 | Sponsor Protocol Number: RC 05/06 | Start Date*: 2008-07-07 | |||||||||||
Sponsor Name:ISTITUTO PER L'INFANZIA BURLO GAROFOLO | |||||||||||||
Full Title: Randomised controlled trial on efficacy and safety of short term versus long term antibiotic therapy for pyelonephritis in childhood. | |||||||||||||
Medical condition: Acute pyelonephritis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003704-31 | Sponsor Protocol Number: ARG-16 | Start Date*: 2019-05-17 |
Sponsor Name:Uppsala University | ||
Full Title: Impact on the intestinal microbiota during antibiotic treatment | ||
Medical condition: Impact on the intestinal microbiota during antibiotic treatment | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002823-27 | Sponsor Protocol Number: GAVALAGG | Start Date*: 2016-11-17 | |||||||||||
Sponsor Name:INFECTOPHARM Arzneimittel GmbH | |||||||||||||
Full Title: Placebo-kontrollierte, multizentrische, randomisierte, doppelblinde Phase III-Studie zur Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie durch add-on-Gabe v... | |||||||||||||
Medical condition: Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000338-20 | Sponsor Protocol Number: MK-7655A-021 | Start Date*: 2019-06-26 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Tha... | |||||||||||||
Medical condition: Treatment of bacterial infections in pediatric populations | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) PL (Completed) Outside EU/EEA ES (Completed) BG (Completed) GR (Completed) NO (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
